Decision of the EEA Joint Committee No 218/2014 of 24 October 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/1442]
Date: 2014-10-24
Institutions: EEA Joint Committee
Subjects: EU control, European Economic Area, chemical product, market approval, marketing standard, mutual recognition principle, plant health control, plant health product, revision of an agreement




L_2015230EN.01001601.xml










3.9.2015   


EN


Official Journal of the European Union


L 230/16








            DECISION OF THE EEA JOINT COMMITTEE
         
No 218/2014
of 24 October 2014
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/1442]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Regulation (EU) No 334/2014 of the European Parliament and of the Council of 11 March 2014 amending Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products, with regard to certain conditions for access to the market (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) No 405/2014 of 23 April 2014 approving lauric acid as an existing active substance for use in biocidal products for product-type 19 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) No 406/2014 of 23 April 2014 to approve ethyl butylacetylaminopropionate as an existing active substance for use in biocidal products for product-type 19 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) No 407/2014 of 23 April 2014 approving transfluthrin as an existing active substance for use in biocidal products for product-type 18 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) No 408/2014 of 23 April 2014 approving synthetic amorphous silicon dioxide as an existing active substance for use in biocidal products for product-type 18 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) No 437/2014 of 29 April 2014 approving 4,5-Dichloro-2-octyl-2H-isothiazol-3-one as an existing active substance for use in biocidal products for product-type 21 (6) is to be incorporated into the EEA Agreement.












(7)


Commission Implementing Regulation (EU) No 438/2014 of 29 April 2014 approving cyproconazole as an existing active substance for use in biocidal products for product-type 8 (7) is to be incorporated into the EEA Agreement.












(8)


Commission Implementing Decision 2014/227/EU of 24 April 2014 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (8) is to be incorporated into the EEA Agreement.












(9)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






(1)


the following indent is added in point 12n (Regulation (EU) No 528/2012 of the European Parliament and of the Council):






‘—



32014 R 0334: Regulation (EU) No 334/2014 of the European Parliament and of the Council of 11 March 2014 (OJ L 103, 5.4.2014, p. 22).’;














(2)


the following points are inserted after point 12ns (Commission Implementing Regulation (EU) No 94/2014):






‘12nt.



32014 R 0405: Commission Implementing Regulation (EU) No 405/2014 of 23 April 2014 approving lauric acid as an existing active substance for use in biocidal products for product-type 19 (OJ L 121, 24.4.2014, p. 8).










12nu.



32014 R 0406: Commission Implementing Regulation (EU) No 406/2014 of 23 April 2014 to approve ethyl butylacetylaminopropionate as an existing active substance for use in biocidal products for product-type 19 (OJ L 121, 24.4.2014, p. 11).










12nv.



32014 R 0407: Commission Implementing Regulation (EU) No 407/2014 of 23 April 2014 approving transfluthrin as an existing active substance for use in biocidal products for product-type 18 (OJ L 121, 24.4.2014, p. 14).










12nw.



32014 R 0408: Commission Implementing Regulation (EU) No 408/2014 of 23 April 2014 approving synthetic amorphous silicon dioxide as an existing active substance for use in biocidal products for product-type 18 (OJ L 121, 24.4.2014, p. 17).










12nx.



32014 D 0227: Commission Implementing Decision 2014/227/EU of 24 April 2014 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 124, 25.4.2014, p. 27).










12ny.



32014 R 0437: Commission Implementing Regulation (EU) No 437/2014 of 29 April 2014 approving 4,5-Dichloro-2-octyl-2H-isothiazol-3-one as an existing active substance for use in biocidal products for product-type 21 (OJ L 128, 30.4.2014, p. 64).










12nz.



32014 R 0438: Commission Implementing Regulation (EU) No 438/2014 of 29 April 2014 approving cyproconazole as an existing active substance for use in biocidal products for product-type 8 (OJ L 128, 30.4.2014, p. 68).’.










Article 2
The texts of Regulation (EU) No 334/2014 and Implementing Regulations (EU) No 405/2014, (EU) No 406/2014, (EU) No 407/2014, (EU) No 408/2014, (EU) No 437/2014 and (EU) No 438/2014 and Implementing Decision 2014/227/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 1 November 2014, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 24 October 2014.


For the EEA Joint Committee


The President

Kurt JÄGER
            





(1)  
            OJ L 103, 5.4.2014, p. 22.

(2)  
            OJ L 121, 24.4.2014, p. 8.

(3)  
            OJ L 121, 24.4.2014, p. 11.

(4)  
            OJ L 121, 24.4.2014, p. 14.

(5)  
            OJ L 121, 24.4.2014, p. 17.

(6)  
            OJ L 128, 30.4.2014, p. 64.

(7)  
            OJ L 128, 30.4.2014, p. 68.

(8)  
            OJ L 124, 25.4.2014, p. 27.

(*1)  No constitutional requirements indicated.